Publication:
Plasmid DNA encoding neutralizing human monoclonal antibody without enhancing activity protects against dengue virus infection in mice

dc.contributor.authorSurachet Benjathummaraken_US
dc.contributor.authorAtsushi Yamanakaen_US
dc.contributor.authorThanyaluk Krasaeen_US
dc.contributor.authorChonlatip Pipattanaboonen_US
dc.contributor.authorSubenya Injampaen_US
dc.contributor.authorPannamthip Pitaksajjakulen_US
dc.contributor.authorPongrama Ramasootaen_US
dc.contributor.otherFaculty of Tropical Medicine, Mahidol Universityen_US
dc.contributor.otherFaculty of Medicine, Khon Kaen Universityen_US
dc.contributor.otherResearch Institute for Microbial Diseasesen_US
dc.contributor.otherKing Mongkut's Institute of Technology Ladkrabangen_US
dc.date.accessioned2022-08-04T09:19:10Z
dc.date.available2022-08-04T09:19:10Z
dc.date.issued2021-07-01en_US
dc.description.abstractObjective: To evaluate the expression of DNA plasmid-harboring modified antibody gene that produces neutralizing human monoclonal antibodies against four serotypes of dengue virus (DENV) without enhancing activity in BALB/c mice. Methods: We constructed pFUSE-based vectors (pFUSE-1G7C2-hVH and pFUSE-1G7C2-hVL) containing genes encoding the variable domains of the heavy or light chain of the anti-dengue virus antibody 1G7C2, a human IgG1 that has been characterized for its neutralizing activity to DENV-1-4. Leucine (L) at positions 234 and 235 on the Fc CH2 domain in pFUSE-1G7C2-hVH was mutated to alanine (A) (LALA mutation) by site direct mutagenesis, and the new plasmid was termed pFUSE-1G7C2-hVH-LALA. An equal amount of pFUSE-1G7C2-hVL and 1G7C2hG1-LALA plasmids were co-Transfected into Chinese hamster ovary cells (CHO-K1) and a single dose of 100 μg 1G7C2-hG1-LALA plasmid was intramuscularly injected, followed by electroporation in BALB/c mice. The secreted 1G7C2-hG1-LALA antibodies in cell culture supernatant and mouse serum were examined for their biological functions, neutralization and enhancing activity. Results: The co-Transfection of heavy-And light-chain 1G7C2-hG1-LALA plasmids in CHO-K1 cells produced approximately 3 900 ng/mL human IgG and neutralized 90%-100% all four DENV, with no enhancing activity. Furthermore, the modified human IgG was produced more than 1 000 ng/mL in mouse serum on day 7 post plasmid injection and showed cross-neutralization to four DENV serotypes. Subsequently, antibody production and neutralization decreased rapidly. Nevertheless, the secreted neutralizing 1G7C2-hG1-LALA in mouse serum demonstrated complete absence of enhancing activities to all DENV serotypes. Conclusions: These findings reveal that a new modified 1G7C2-hG1-LALA expressing plasmid based on gene transfer is a possible therapeutic antibody candidate against DENV infection.en_US
dc.identifier.citationAsian Pacific Journal of Tropical Medicine. Vol.14, No.7 (2021), 299-308en_US
dc.identifier.doi10.4103/1995-7645.320520en_US
dc.identifier.issn19957645en_US
dc.identifier.other2-s2.0-85111158750en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/78060
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85111158750&origin=inwarden_US
dc.subjectMedicineen_US
dc.titlePlasmid DNA encoding neutralizing human monoclonal antibody without enhancing activity protects against dengue virus infection in miceen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85111158750&origin=inwarden_US

Files

Collections